Guardian Wealth Advisors (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
437
+38
| +10% | +$20K | 0.02% | 309 |
|
|
2025
Q1 | $253K | Buy |
399
+2
| +0.5% | +$1.27K | 0.02% | 274 |
|
|
2024
Q4 | $283K | Sell |
397
-15
| -4% | -$10.7K | 0.02% | 258 |
|
|
2024
Q3 | $433K | Sell |
412
-12
| -3% | -$12.6K | 0.05% | 177 |
|
|
2024
Q2 | $446K | Sell |
424
-2
| -0.5% | -$2.1K | 0.05% | 170 |
|
|
2024
Q1 | $410K | Buy |
426
+21
| +5% | +$20.2K | 0.05% | 180 |
|
|
2023
Q4 | $356K | Sell |
405
-14
| -3% | -$12.3K | 0.05% | 174 |
|
|
2023
Q3 | $345K | Buy |
419
+30
| +8% | +$24.7K | 0.06% | 167 |
|
|
2023
Q2 | $280K | Buy |
389
+36
| +10% | +$25.9K | 0.05% | 176 |
|
|
2023
Q1 | $290K | Buy |
353
+4
| +1% | +$3.29K | 0.05% | 170 |
|
|
2022
Q4 | $252K | Sell |
349
-140
| -29% | -$101K | 0.05% | 169 |
|
|
2022
Q3 | $337K | Sell |
489
-12
| -2% | -$8.27K | 0.06% | 135 |
|
|
2022
Q2 | $296K | Sell |
501
-73
| -13% | -$43.1K | 0.05% | 148 |
|
|
2022
Q1 | $401K | Sell |
574
-78
| -12% | -$54.5K | 0.17% | 100 |
|
|
2021
Q4 | $412K | Buy |
+652
| New | +$412K | 0.18% | 103 |
|